Showing results (51-60 of 371) with videos related to

Sort By:
Pageof 38
American Journal of Nuclear Medicine and Molecular Imaging|January 31, 2019
FDG PET imaging in multiple myeloma: implications for response assessments in clinical trialsSuchitra Sundaram, James Driscoll, Mariano Fernandez-Ulloa, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2024
SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell ProgramTimothy J Voorhees, Evandro Bezerra, Nathan Denlinger, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitorsRichard Champlin, Elias Jabbour, Partow Kebriaei, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor eraIlana Zalcberg Renault, Vanesa Scholl, Rocio Hassan, et al.
Frontiers in Oncology|June 26, 2024
Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphomaAna Costa Cordeiro, George Durisek, Marjorie Vieira Batista, et al.
Current Hematologic Malignancy Reports|December 31, 2010
The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settingsCelso Arrais Rodrigues, Poliana Alves Patah, Yana A S Novis, et al.
Brazilian Journal of Otorhinolaryngology|August 19, 2006
Self-medication profile of ENT patientsAlexandre Barbosa Servidoni, Liliane Coelho, Marcos de Lima Navarro, et al.
Pageof 38